Clinical Trials

174 enrolled

Lymphoma

NCT05490953 2023-04-18

Enhancing Effect on Tumour Apoptosis With the Use of Pentoxifylline in Patients With Hodgkin Lymphoma

30 enrolled

Hodgkin Disease

NCT05786989 2023-03-28

Selinexor Combined With R-GemOx as Second-line Treatment in Patients With Diffuse Large B-cell Lymphoma

32 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT05510544 2023-03-13

Plerixafor for Poorly Mobilized Lymphoma

140 enrolled

Lymphoma

NCT02752815 2022-12-05

Reduced Chemotherapy in Low Risk DLBCL

290 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT05340985 2022-04-22

Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis

54 enrolled

Multiple Sclerosis, Relapsing-Remitting, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05191225 2022-03-31

Ultrafast Truxima Infusion in Non-Hodgkin's Lymphoma: Txagorapid Study

48 enrolled

Lymphoma, Non-Hodgkin

NCT01358201 2022-01-19

PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 Years

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01366898 2022-01-19

Protocol For the Treatment Acute Lymphoblastic Leukemia With Ph 'Negative in Elderly Patients (> 55 Years)

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05137860 2022-01-18

Efficacy of the Use of Bortezomib for the Treatment of Relapsed Leukemia or Positive MRD

56 enrolled

Recurrence, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05133310 2022-01-04

Effect of Simvastatin on Sepsis and Febrile Neutropenia in Patients With Acute Lymphoblastic Leukemia

Classical hematologyLymphoidOther hematologic neoplasm

108 enrolled

Sprains and Strains, Sepsis, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Febrile Neutropenia

NCT04999878 2021-08-11

RUE-DDGP

30 enrolled

LymphoidMyeloid

Lymphohistiocytosis, Hemophagocytic, Lymphoma, Extranodal NK-T-Cell

NCT04842318 2021-04-13

Rituximab Maintenance Treatment of Newly Diagnosed Follicular Lymphoma After BR or RCHOP or R2: a Multicenter Clinical Study

789 enrolled

Lymphoma, Follicular

NCT04490590 2020-07-29

A Clinical Trial of Chidamide Combined With Etoposide in Relapsed or Refractory NK/T-cell Lymphoma

30 enrolled

Lymphoma, Extranodal NK-T-Cell

NCT04040491 2020-05-12

PD-1 Antibody, Chidamide, Lenalidomide and Gemcitabine for Peripheral T-cell Lymphoma

Lymphoma, T-Cell, Peripheral

NCT04323059 2020-03-30

Effectiveness, Tolerability and Safety of Three Formulations in Underfives With Moderate Acute Malnutrition

80 enrolled

Lymphoma, Follicular, Malnutrition

NCT04152577 2019-11-05

R2 and Combination Chemotherapy Versus R and Combination Chemotherapy in Newly Diagnosed Highly Aggressive B-NHL

200 enrolled

Lymphoma, B-Cell

NCT04134247 2019-10-22

Study of PD-1 Monoclonal Antibody in Combination With Chemotherapy in Patients With RR NHL

120 enrolled

Lymphoma, Non-Hodgkin

NCT04083079 2019-09-10

Cost-Effectiveness Study of PEG-rhG-CSF in Prophylactic Treatment of Neutropenia After Chemotherapy in Lymphoma

250 enrolled

Lymphoma, Non-Hodgkin

NCT04038411 2019-07-30

PD-1 Antibody, Chidamide, Lenalidomide and Etoposide for Relapsed or Refractory NK/T Cell Lymphoma

50 enrolled

Lymphoma, Extranodal NK-T-Cell

NCT03920813 2019-04-23

Determinants of Mercaptopurine Toxicity in Paediatric Acute Lymphoblastic Leukemia Maintenance Therapy

500 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02526823 2019-04-02

Clinical Application of Polyethylene Glycol Liposome Doxorubicin (PLD) in Primary Lymphoma

360 enrolled

Lymphoma

NCT02933333 2018-10-17

G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor

CNSGastrointestinalLymphoidOther hematologic neoplasmOther solid neoplasm

405 enrolled

Lymphoma, Neuroblastoma, Retinoblastoma, Leukemia, Myeloid, Acute, Hepatoblastoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03558412 2018-09-14

A Clinical Trial of Decitabine in Relapsed or Refractory T-lymphoblastic Lymphoma

40 enrolled

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT03579082 2018-09-14

A Clinical Trial of Decitabine in Relapse and Refractory Diffuse Large B Cell Lymphoma

60 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT03631862 2018-08-15

Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

Lymphoma, T-Cell, Peripheral

NCT03071822 2018-06-11

Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell Lymphomas

50 enrolled

Lymphoma, T-Cell, Peripheral

NCT03513601 2018-05-01

Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma

20 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT01906671 2018-04-20

Study on Two Different Formulations of 6-mercaptopurine. Tablet Versus Oral Liquid

16 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01746992 2017-11-14

CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma

200 enrolled

DermatologicLymphoid

Subcutaneous panniculitis-like T-cell lymphoma, Immunoblastic Lymphadenopathy, Enteropathy-Associated T-Cell Lymphoma

NCT03150602 2017-05-12

A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy

22 enrolled

Lymphoma, T-Cell, Peripheral, Disease Progression

NCT01765231 2017-01-10

Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma

190 enrolled

Hepatitis B, Lymphoma

NCT01768195 2017-01-10

Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy

80 enrolled

Hepatitis B, Lymphoma

NCT03010579 2017-01-05

Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation

Classical hematologyLymphoid

70 enrolled

Anemia, Lymphoma

NCT02576327 2016-12-30

A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation

130 enrolled

Lymphoma, Vomiting, Hematologic Neoplasms

NCT02585947 2016-12-21

To Compare the Efficacy of a Prophylactic Use of Tenofovir by Duration for the Non-Hodgkin's Lymphoma

90 enrolled

Burkitt Lymphoma, Lymphoma, Non-Hodgkin

NCT02996617 2016-12-19

PEG-rhG-CSF in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy to Prevent Neutropenia

240 enrolled

Lymphoma, Non-Hodgkin, Neutropenia, Lymphoma, B-Cell, Lymphoma, T-Cell

NCT02992834 2016-12-14

Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for CD19+ B Cell Lymphoma

10 enrolled

Lymphoma, B-Cell

NCT02938741 2016-10-25

ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors

130 enrolled

Lymphoma, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02929615 2016-10-12

Study of Standard and Individualized Treatment Model for Relapse and Refractory Lymphatic System Malignant Tumors

50 enrolled

Lymphoma

NCT02894645 2016-09-30

Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study

500 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02905916 2016-09-19

The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy

217 enrolled

BreastLymphoidSarcoma

Bone Neoplasms, Breast Neoplasms, Lymphoma

NCT02905942 2016-09-19

PEG-rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation

96 enrolled

Lymphoma

NCT01698866 2016-06-16

EVACC-B

40 enrolled

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

NCT01949818 2015-12-30

Treatment of Diffuse Large B Cell Lymphoma

120 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT01873807 2015-10-09

HITA

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01501136 2015-07-17

CTTNKTL-I/II

200 enrolled

Lymphoma, Extranodal NK-T-Cell

NCT01501149 2015-07-17

CTTNKTL-Ⅲ/Ⅳ

80 enrolled

Lymphoma, Extranodal NK-T-Cell

NCT02347878 2015-01-27

Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH)

85 enrolled